Existing rodent models of human tauopathy invariably involve overexpression of mutant or wild-type tau under the control of a variety of different promoters (Denk and Wade-Martins, 2009; Zilka et al., 2009; Noble et al., 2010). This evidence concerns the gene MAPT and tauopathy.